1
|
Fernández Ledesma B, Mendoza-Palomar N, Melendo Pérez S, Fernández-Polo A, Renedo Miró B, Pau Parra A, Luque Pardos S, Grau Cerrato S, Vima Bofarull J, Martín-Gómez MT, Pujol Jover M, Benítez-Carbante MI, Díaz de Heredia C, Soler-Palacin P. Isavuconazole use and TDM in real-world pediatric practice. Antimicrob Agents Chemother 2023; 67:e0082923. [PMID: 37962334 PMCID: PMC10720574 DOI: 10.1128/aac.00829-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Accepted: 09/28/2023] [Indexed: 11/15/2023] Open
Abstract
Isavuconazole (ISA) is approved for treating invasive aspergillosis and mucormycosis in adults, but its use in children remains off-label. We report on the use of ISA in real-world pediatric practice with 15 patients receiving ISA for treatment of invasive fungal infections. Therapeutic drug monitoring (TDM) was performed in all patients, with 52/111 (46.8%) Ctrough determinations out of range, thus supporting the need for TDM in children, especially those receiving extracorporeal membrane oxygenation (ECMO).
Collapse
Affiliation(s)
- Berta Fernández Ledesma
- Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Infantil. Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - Natalia Mendoza-Palomar
- Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Infantil. Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - Susana Melendo Pérez
- Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Infantil. Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - Aurora Fernández-Polo
- Pharmacy Department, Hospital Infantil, Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - Berta Renedo Miró
- Pharmacy Department, Hospital Infantil, Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - Alba Pau Parra
- Pharmacy Department, Hospital Infantil, Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | | | | | - Jaume Vima Bofarull
- Department of Clinical Biochemistry, Central Clinical Laboratories, Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - María Teresa Martín-Gómez
- Microbiology Department, Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
| | - Montserrat Pujol Jover
- Pediatric Intensive Care Unit, Hospital Infantil, Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - Maria Isabel Benítez-Carbante
- Pediatric Oncology and Hematology Department, Hospital Infantil. Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - Cristina Díaz de Heredia
- Pediatric Oncology and Hematology Department, Hospital Infantil. Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Barcelona, Catalonia, Spain
| | - Pere Soler-Palacin
- Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Infantil. Vall d’Hebron Barcelona Hospital Campus, Institut de Recerca Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain
| |
Collapse
|